John counsels life sciences companies, including Bio-AI, space pharma/biotech, neurotechnology, biotechnology, pharmaceutical, diagnostics, and medical device companies and their investors, in structuring and negotiating complex bet-the-company strategic intellectual property transactions, including strategic alliances, joint ventures, global partnering deals, collaborations, spinouts, and strategic mergers and acquisitions.他还代表金融机构是主要知识产权顾问,并为生命科学的科学,商业和知识产权尽职调查公共和私人融资,合并和收购交易以及套利。他还咨询了复杂的生命科学诉讼。他的战略交易中有90%超过90%是跨境,他在亚洲,欧洲和南美拥有丰富的经验。
主要关键词